Capital Signal

Mayne Pharma Group Limited (ASX: MYX)

Sector: Health Care

Market cap: A$208M (as of 2 Nov 2026)

Develops, manufactures and markets pharmaceutical products globally

Data as of 2 Nov 2026.

Substantial holders — latest moves

DateHolderMoveHoldingSource
26 June 2026Funicular Funds, LPIncrease8.06% → 9.9%Filing ↗
18 June 2026Funicular Funds, LPIncrease6.3% → 8.06%Filing ↗
24 Mar 2026Funicular Funds, LPEntry?% → 6.3%Filing ↗
2 Mar 2026Mitsubishi UFJ Financial Group, Inc.Exit—Filing ↗
2 Mar 2026Trium Capital LLP (Trium Capital), Trium Khartes Master Fund Limited (TKMFL), Chi-Rho Multi-Strategy Master Fund Ltd (Chi-Rho), AIS Acadia Master Fund Ltd (AIS), Maple Leaf Patriot Core LLC (MLPC), Eagle Harbor Multi-Strategy Master Fund Limited (Eagle Harbor), Trium Capital Segregated Portfolio, a segregated portfolio of PC Map SPC, a Cayman Islands segregated portfolio company (Trium Capital Segregated Portfolio), FMAP TRM Ltd (FMAP TRM)Entry?% → 5.020%Filing ↗

Director trades — on-market

DateDirectorTradeSource
1 Dec 2023Frank Charles Condella JrBought 7,154Filing ↗
25 Oct 2023Dr Kathryn (Katie) MacFarlaneBought 18,000Filing ↗
24 Oct 2023Shawn Patrick O’BrienBought 37,041Filing ↗
20 Oct 2023Ms Ann CustinBought 20 October 2023: 6,250; 23 October 2023: 6,037Filing ↗
17 Apr 2023Ms Ann CustinBought 9,075Filing ↗

Ask about MYX in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has MYX raised money in the last year, and at what discount?
  • What was MYX's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading MYX…

Mayne Pharma Group Limited (ASX: MYX): capital raises, holders, director trades | Capital Signal